SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001214659-24-010336
Filing Date
2024-05-31
Accepted
2024-05-31 16:59:37
Documents
6
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 f530240def14a.htm DEF 14A 153870
2 GRAPHIC alzamendlogo_regmark.jpg GRAPHIC 17222
3 GRAPHIC exproxy-001.jpg GRAPHIC 64060
4 GRAPHIC exproxy-002.jpg GRAPHIC 78773
5 GRAPHIC exproxy-003.jpg GRAPHIC 51575
6 GRAPHIC exproxy-004.jpg GRAPHIC 54950
  Complete submission text file 0001214659-24-010336.txt   522668
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-40483 | Film No.: 241010638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)